COLLPLANT BIOTECHNOLOGIES LT
OPHINASDAQ๐ #4806 by market capEarnings Dec 2US Equity
$3.13โผ $0.08 (โ2.49%)
Market closed ยท at closeTrack OPHI
Get earnings, price moves & breaking news on Telegram
24hโผ 2.5%
7dโผ 13.4%
14dโผ 22.8%
30dโผ 12.1%
ytdโผ 77.8%
1yโผ 85.0%
๐ฆMarket Cap
$7M
Small Cap
๐Revenue Growth (YoY)
-86.8%
Declining
๐Gross Margin
-321.7%
Thin
๐ตFCF Margin
โ
โ๏ธP/S Ratio
27.6x
Expensive
Otter Score
โ
Insufficient data
Trading Snapshot
- Day Range
- $3.13 โ $3.71
- 52-Week Range
- $2.64 โ $22.50
- Volume (shares)
- 45,268
- Avg Volume (shares)
- โ
- Shares Outstanding
- 2.3M
- Next Earnings
- 2026-12-02
Fundamentals Snapshot
- Annual Revenue
- โ
- Last Q Revenue
- โ
- P/E Ratio
- โ
- P/S Ratio
- 27.6x
- EPS (TTM)
- $-9.39
- Dividend Yield
- โ
COLLPLANT BIOTECHNOLOGIES LT
OPHIFinancial Trends
Financial history unavailable.
About COLLPLANT BIOTECHNOLOGIES LT
CollPlant Biotechnologies Ltd. operates as a regenerative and aesthetic medicine company. It engages in the research, development, manufacture, and marketing of medical products for tissue repair such as bioprinting of tissues and organs, and medical aesthetics. Its products include VergenixSTR, VergenixFG, and Collink.3D. The company was founded by Oded Shoseyov in June 2004 and is headquartered in Rehovot, Israel.
๐ฆฆ
Otter Score Breakdown
How it's scoredFive components, each rated 1โ5โ and equally weighted (20%), averaged to a 0โ100 score:๐ Quality โ gross margin๐ Growth โ revenue YoYโ๏ธ Valuation โ P/S ratioโก Momentum โ 30-day price change๐ง Dilution โ 1-yr share issuance (buybacks score higher)Insufficient data for all five components.
๐Qualityโ
โ
โ
โ
โ
๐Growthโ
โ
โ
โ
โ
โ๏ธValuationโ
โ
โ
โ
โ
Overall Score
Insufficient data
โ/100
Analyst data unavailable.
Latest News & Updates
News unavailable.